Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

Abstract Background Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, opting for active symptom control instead. The aim...

Full description

Bibliographic Details
Main Authors: Anna C. Bibby, Duneesha De Fonseka, Anna J. Morley, Emma Keenan, Alfredo Addeo, Sarah Smith, Anthony J. Edey, Nick A. Maskell
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Palliative Care
Subjects:
Mesothelioma
Active symptom control
Chemotherapy
Treatment decisions
Best supportive care
Online Access:http://link.springer.com/article/10.1186/s12904-017-0255-3

Internet

http://link.springer.com/article/10.1186/s12904-017-0255-3

Similar Items